Skip to content
FY'25FY'24FY'23FY'22
$2.2B$1.24B+33.3%$933.01M+32.9%
$235.24M+140%-$581.63M+17.3%-$703.49M-68.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Sarepta Therapeutics, Inc.'s income statement data come from?
Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.